Gergana Galabova‐Kovacs

Author

Also Known As

G Galabova-Kovacs, Gergana Galabova-Kovacs, Gergana Galabova‐Kovacs

Publications

602

Citations

H-Index

Concepts

All Affiliations

Gergana Galabova‐Kovacs is an author at Max Perutz Labs specializing in medicine, oncology, and measurement.

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	147
2	Education	1	1	171
3	Public Health	1	1	27
4	Cell Biology	1	1	20
5	Endocrinology	1	1	27

Gergana Galabova‐Kovacs

Publications

509

Citations

H-Index

Page 1

	Year	Citations
A Mek1–Mek2 heterodimer determines the strength and duration of the Erk signal Federica Catalanotti, Gloria Reyes, Veronika Jesenberger, Nature Structural & Molecular Biology PhysicsMeasurementIntensity ModulationEducationErk Signal	2009	171
Essential role of B-Raf in ERK activation during extraembryonic development Gergana Galabova‐Kovacs, Dana Matzen, Daniela Piazzolla, Proceedings of the National Academy of Sciences	2006	109
Raf-1 Addiction in Ras-Induced Skin Carcinogenesis Karin Ehrenreiter, Florian Kern, Vanishree Velamoor, Cancer Cell Oncogenic AgentMedicinePhotocarcinogenesisRaf-1 AddictionDermatology	2009	100
Essential role of B-Raf in oligodendrocyte maturation and myelination during postnatal central nervous system development Gergana Galabova‐Kovacs, Federica Catalanotti, Dana Matzen, The Journal of Cell Biology	2008	82
Steroid receptors in canine endometrial cells can be regulated by estrogen and progesterone under in vitro conditions Gergana Galabova‐Kovacs, Ingrid Walter, Christine Aurich, Theriogenology Developmental BiologyMedicineHormonal ReceptorUterine ReceptivitySteroid Receptors	2003	27
B-Raf is required for ERK activation and tumor progression in a mouse model of pancreatic β-cell carcinogenesis Izabela Sobczak, Gergana Galabova‐Kovacs, Iwona Sadzak, Oncogene OncologyPancreatic β-Cell CarcinogenesisPancreatic CancerMedicineCancer Cell Biology	2008	20

Page 1